Numerous emerging therapies for focused treatments on psoriasis and psoriatic arthritis are authorized. Tumor necrosis factor (TNF) inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, selective co-stimulation modulators, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors are among the biologics that are added to the treatment regime for psoriasis and PsA in recent years. Join an exclusive session on "Emerging Treatments for Psoriasis” with eminent dermatologist Dr. Col. Biju Vasudevan on 21 st July 2025 , from 11:00 AM IST onwards.
Moderator : Dr. Rashmi Mahajan Stay Tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the information's suitability, reliability, or adequacy, including data visualization elements and graphics. We do…
